3,758 results
·
29ms
·
Sources: EU EUDAMED, US FDA
Filters
Classification: FDA Class 2
×
Dna-Probe, B And T Lymphocyte
FDA Pre-Market Approval
FDA Class 2
·ONCOR B/T GENE REARRANGEMENT TEST
Dna-Probe, B And T Lymphocyte
FDA Pre-Market Approval
FDA Class 2
·ONCOR B/T GENE REARRANGEMENT TEST
Dna-Probe, B And T Lymphocyte
FDA Pre-Market Approval
FDA Class 2
·ONCOR B/T GENE REARRANGEMENT TEST
HL168F
FDA 510(k)
FDA Class 2
·Cardiovascular
BIOTOP HOOKSAFE LUER-LOCK SAFETY SYRINGE, MODELS 3CC/ML, 5CC/ML AND 10CC/ML
FDA 510(k)
FDA Class 2
·General Hospital
HL168E
FDA 510(k)
FDA Class 2
·Cardiovascular
HL168B
FDA 510(k)
FDA Class 2
·Cardiovascular
HL168T
FDA 510(k)
FDA Class 2
·Cardiovascular
HL888JF
FDA 510(k)
FDA Class 2
·Cardiovascular
ROSSMAX AUTOMATIC WRISTWATCH BLOOD PRESSURE MONITOR, MODEL RM-4000
FDA 510(k)
FDA Class 2
·Cardiovascular
MODIFICATION TO:HL168D BLOOD PRESSURE MONITOR
FDA 510(k)
FDA Class 2
·Cardiovascular
MODIFICATION TO: HL168W TOUCH SCREEN
FDA 510(k)
FDA Class 2
·Cardiovascular
HL888HM
FDA 510(k)
FDA Class 2
·Cardiovascular
HL888
FDA 510(k)
FDA Class 2
·Cardiovascular
ROSSMAX AUTOMATIC WRISTWATCH BLOOD PRESSURE MONITOR, MODEL RM-4200
FDA 510(k)
FDA Class 2
·Cardiovascular
HL148 & HL168
FDA 510(k)
FDA Class 2
·Cardiovascular
HL888HA
FDA 510(k)
FDA Class 2
·Cardiovascular
Test, Alpha Fetoprotein L3 Subfraction (Afp-L3%), For Hepatocellular Carcinoma Risk Assessment
FDA classification
FDA Class 2
·Test, Alpha Fetoprotein L3 Subfraction (Afp-L3%), For Hepatocellular Carcinoma Risk Assessment
TYTAN PROFESSIONAL /ECONOMY SERIES SPHYGMOMANOMETER, NO 710/NO 700
FDA 510(k)
FDA Class 2
·Cardiovascular
Test, Epithelial Ovarian Tumor Associated Antigen (He4)
FDA classification
FDA Class 2
·Test, Epithelial Ovarian Tumor Associated Antigen (He4)